Metalink (MTLK) Research & Development (2012)

Metalink (MTLK) posted quarterly Research & Development of -$1000.0 for Q4 2012, down 100.91% quarter-over-quarter from $110000.0 in Q3 2012.

Metalink (MTLK) Research & Development (2012) Analysis & Trends

Metalink's Research & Development history runs 1 years deep, the most recent figure standing at -$1000.0 for Q4 2012.

In Q4 2012, Research & Development changed N/A year-over-year to -$1000.0; the TTM figure through Dec 2012 stood at $305000.0 (changed N/A YoY), while the FY2015 annual figure was $84000.0, up 2700.0% from the prior year.
Research & Development for Q4 2012 stood at -$1000.0, down from $110000.0 in the prior quarter.
The five-year high for Research & Development was $110000.0 in Q3 2012, with the low at -$1000.0 in Q4 2012.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	R&D (Qtr)
1	Launch Two Acquisition	557.86 Mn	557.86 Mn	-	-
2	Drugs Made In America Acquisition	507.00 Mn	507.00 Mn	-	-
3	Cantor Equity Partners IV	467.55 Mn	467.55 Mn	-	-
4	GP-Act III Acquisition	401.06 Mn	401.06 Mn	-	-
5	Aldel Financial	397.49 Mn	397.49 Mn	-	-
6	Gores Holdings X	381.05 Mn	380.85 Mn	-	-
7	Agriculture & Natural Solutions Acquisition	377.29 Mn	377.04 Mn	-	-
8	Blue Water Acquisition Corp. III	342.12 Mn	342.08 Mn	-	-
9	Berto Acquisition	313.96 Mn	313.81 Mn	-	-
10	Metalink	263,684.39	263,684.39	-	-

Download Data